Milestone Pharmaceuticals (MIST) Total Non-Current Liabilities: 2021
Historic Total Non-Current Liabilities for Milestone Pharmaceuticals (MIST) over the last 1 years, with Dec 2021 value amounting to -$45.7 million.
- Milestone Pharmaceuticals' Total Non-Current Liabilities rose 4.81% to -$44.3 million in Q3 2022 from the same period last year, while for Sep 2022 it was -$44.3 million, marking a year-over-year increase of 4.81%. This contributed to the annual value of -$45.7 million for FY2021, which is N/A change from last year.
- Milestone Pharmaceuticals' Total Non-Current Liabilities amounted to -$45.7 million in FY2021.
- In the past 5 years, Milestone Pharmaceuticals' Total Non-Current Liabilities registered a high of -$45.7 million during FY2021, and its lowest value of -$45.7 million during FY2021.
- In the last 1 years, Milestone Pharmaceuticals' Total Non-Current Liabilities had a median value of -$45.7 million in 2021 and averaged -$45.7 million.